TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Feb 3, 2026 · Cline Christopher R. sold 7,242 shares at $32.12/share ($232.6K); was granted 28.13K shares

Cline Christopher R. sold 7,242 shares at $32.12/share ($232.6K); was granted 28.13K shares

xslF345X05/form4-02032026_090208.xml

xslF345X05/form4-02032026_090208.xmlSEC.gov

Graphics and non-inline formats (not embedded below).